Henry Malter, Ph.D., is a world-renowned scientist with 25 years of experience in reproductive medicine and human genetics. Dr Malter holds a High Complexity Laboratory Director (HCLD) certification from the American Board of Bioanalysis. Dr Malter began his career managing the laboratory of in vitro fertilization pioneer Benjamin Brackett, who specialized in mammalian reproductive research. In the mid-80s, Malter joined Dr Jacques Cohen's laboratory to bring some of these scientific advancements to the human clinical setting. Malter developed and performed the first successful human clinical micromanipulation procedure leading to the birth of a healthy baby. This development established an entirely new paradigm for human clinical embryology eventually leading to multiple techniques that currently form the standard of treatment in the human ART laboratory. This original technique, partial zona dissection, is still used in clinics around the world for embryo biopsy and other procedures. Malter, Cohen and their clinical team also developed assisted hatching,which promotes embryonic hatching at the time of implantation and is also a current standard of treatment in human ART. In mid-career, Dr Malter pursued a Ph.D. degree in human molecular genetics in the Howard Hughes Medical Institute laboratory of Dr Stephen Warren at Emory University. Dr Warren is a world-renowned human geneticist who led the international team that discovered the mutation responsible for human Fragile-X syndrome. While in Warren's lab, Dr Malter pursued basic research related to the molecular and genetic basis of Fragile X syndrome. This resulted in multiple publications in prestigious scientific journals such as Human Molecular Genetics, Molecular Cell, and a ground-breaking first author Nature Genetics publication presenting the first evidence-based model for the Fragile X mutation process. Dr Malter is also an internationally recognized expert in the field of preimplantation genetic diagnosis (PGD). Dr Malter was one of the founding members of the International PGD Society, PGDIS, and has participated over the past 15 years at PGD symposia from the very first worldwide PGD meeting in 1990. He worked for two years as a traveling consultant for Chicago's prestigious Reproductive Genetics Institute, providing PGD services to client clinics in the US and Europe. Dr Malter remains an in-demand independent PGD consultant embryologist and is one of the few individuals who is certified to act as a molecular and cytogenetic clinical PGD embryologist for the three major PGD laboratory providers. Dr Malter has an impressive publication history extending over a 20-year period, including some of the seminal publications in the human assisted reproductive medicine field. He has authored/co-authored numerous book chapters and the first and definitive textbook on human embryological micromanipulation.